Microcurrent for Fibromyalgia
Active, not recruitingNot applicableNCT04949100
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Explore the use of microcurrent therapy for fibromyalgia patients and evaluate its effect on generalized pain and quality of life. Determine if microcurrent therapy be effectively self-administered by the patient as an adjunct to medical pain management.
Study details
- Official title
- Microcurrent for Fibromyalgia, a Double-Blinded, Placebo-Controlled Study
- Conditions
- Interventions
- Device: Microcurrent Transcutaneous Electrical Nerve Stimulator (TENS) for pain relief
- Device: PLACEBO Microcurrent Transcutaneous Electrical Nerve Stimulator (TENS) for pain relief
- Sponsor
- Paul Crawford
- Organization
- Mike O'Callaghan Military Hospital
- Start date
- 2021-10-25
- Primary completion
- 2026-12
- Sex
- All
- Age range
- from 18 Years to 74 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
\*\*Patients must be able to get care at Nellis Air Force Base (a military installation) in order to participate in this study\*\* Inclusion Criteria: * Male and female Active Duty or DoD beneficiary aged 18-74 years old. * Meets diagnostic criteria of fibromyalgia as defined by the American College of Rheumatology 1990 Criteria 1,18 to be consistent with prior research. * Symptom duration of at least 3 months * Tender points: having \>10/18 tender points * Pain-affected areas includes all quadrants of the body * Other causes excluded clinically * History of a neck injury sometime in their life Exclusion Criteria: * Peripheral neuropathy * Pregnancy * History of: * Brain/spine surgery * Nerve entrapment surgery * Severe bony deformities or contracture * Hypersensitive reaction to the surface electrode * Severe psychological disorders * Current alcohol or drug abuse. (caveat: medical marijuana is permitted) * Active infections * Active cancer * Cardiac arrhythmias (If yes, please list \_\_\_\_\_\_\_\_\_\_\_\_\_) * Received an organ transplant * Pacemakers and electrically implanted electronic devices * Subjects scheduled for surgery will not be eligible to participate in thisstudy until 6 weeks post-surgery.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04949100